Intech Investment Management LLC Has $2.42 Million Holdings in MetLife, Inc. $MET

Key Points

• Intech Investment Management LLC decreased its stake in MetLife by 21.3%, holding $2.42 million worth of shares after selling 8,137 shares in the first quarter.
• MetLife reported earnings of $2.02 per share, missing analysts' estimates of $2.32, with a revenue of $17.34 billion for the quarter, down 2.7% year-over-year.
• The company recently announced a quarterly dividend of $0.5675 per share, representing an annualized yield of 2.8% and a payout ratio of 38.47%.

Intech Investment Management LLC lessened its stake in MetLife, Inc. (NYSE:MET - Free Report) by 21.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,090 shares of the financial services provider's stock after selling 8,137 shares during the quarter. Intech Investment Management LLC's holdings in MetLife were worth $2,416,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in MET. Brighton Jones LLC boosted its holdings in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after buying an additional 351 shares during the period. Sherbrooke Park Advisers LLC acquired a new position in MetLife during the fourth quarter worth $348,000. Toronto Dominion Bank boosted its holdings in MetLife by 6.1% during the fourth quarter. Toronto Dominion Bank now owns 336,124 shares of the financial services provider's stock worth $27,521,000 after purchasing an additional 19,307 shares during the last quarter. State of Wyoming boosted its holdings in MetLife by 85.1% during the fourth quarter. State of Wyoming now owns 4,561 shares of the financial services provider's stock worth $373,000 after purchasing an additional 2,097 shares during the last quarter. Finally, Tidal Investments LLC boosted its holdings in MetLife by 22.8% during the fourth quarter. Tidal Investments LLC now owns 23,671 shares of the financial services provider's stock worth $1,938,000 after purchasing an additional 4,389 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Price Performance

MET stock opened at $80.46 on Tuesday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The firm has a market cap of $53.51 billion, a P/E ratio of 13.64, a P/E/G ratio of 0.73 and a beta of 0.87. The company's 50-day moving average price is $78.27 and its two-hundred day moving average price is $78.21.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The company had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. During the same quarter in the previous year, the business posted $2.28 earnings per share. The company's revenue for the quarter was down 2.7% on a year-over-year basis. On average, analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were issued a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, August 5th. MetLife's payout ratio is presently 38.47%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on MET shares. JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Barclays upped their price target on shares of MetLife from $88.00 to $94.00 and gave the stock an "overweight" rating in a research report on Monday, July 7th. Jefferies Financial Group upped their price target on shares of MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Keefe, Bruyette & Woods dropped their price target on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, August 11th. Finally, UBS Group dropped their price target on shares of MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Eleven investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $95.55.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.